Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie A Cesaretti

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 6, 2007
(125)I monotherapy using D90 implant doses of 180 Gy or greaterJohnny Kao, Nelson N Stone, Amir Lavaf, et al.
Cancer Journal (Sudbury, Mass.)|October 9, 2007
Brachytherapy for the treatment of prostate cancerJamie A Cesaretti, Nelson N Stone, Vassilios M Skouteris, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2009
Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapyAlice Y Ho, Ryan J Burri, Jamie A Cesaretti, et al.
The Journal of Urology|December 19, 2009
Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?Nelson N Stone, David T Marshall, Jonathan J Stone, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2010
Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancerRyan J Burri, Alice Y Ho, Kevin Forsythe, et al.
Brachytherapy|February 8, 2007
Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancerAlice Y Ho, Ryan J Burri, Glenn T Jennings, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2007
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapyJamie A Cesaretti, Richard G Stock, David P Atencio, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapyChristopher A Peters, Richard G Stock, Jamie A Cesaretti, et al.
Radiation Research|June 28, 2008
Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancerRyan J Burri, Richard G Stock, Jamie A Cesaretti, et al.
Cancer|June 19, 2009
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary responseJohnny Kao, Stuart Packer, Ha Linh Vu, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|November 6, 2007
(125)I monotherapy using D90 implant doses of 180 Gy or greaterJohnny Kao, Nelson N Stone, Amir Lavaf, et al.
Cancer Journal (Sudbury, Mass.)|October 9, 2007
Brachytherapy for the treatment of prostate cancerJamie A Cesaretti, Nelson N Stone, Vassilios M Skouteris, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2009
Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapyAlice Y Ho, Ryan J Burri, Jamie A Cesaretti, et al.
The Journal of Urology|December 19, 2009
Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?Nelson N Stone, David T Marshall, Jonathan J Stone, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2010
Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancerRyan J Burri, Alice Y Ho, Kevin Forsythe, et al.
Brachytherapy|February 8, 2007
Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancerAlice Y Ho, Ryan J Burri, Glenn T Jennings, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2007
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapyJamie A Cesaretti, Richard G Stock, David P Atencio, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapyChristopher A Peters, Richard G Stock, Jamie A Cesaretti, et al.
Radiation Research|June 28, 2008
Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancerRyan J Burri, Richard G Stock, Jamie A Cesaretti, et al.
Cancer|June 19, 2009
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary responseJohnny Kao, Stuart Packer, Ha Linh Vu, et al.
Pageof 4